Acadian Asset Management
CHRS icon

Acadian Asset Management’s Coherus Oncology CHRS Stock Holding History

Acadian Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$37K Sell
2025
Q1 		$158K Buy
2024
Q4 		$0 Sell
2024
Q3 		$58K Buy
2024
Q1 		– Sell
2023
Q4 		$1.97M Buy
2022
Q3 		– Sell
2022
Q2 		$41K Buy
2020
Q3 		– Sell
2020
Q2 		$1.56M Sell
2020
Q1 		$3.15M Buy